178 related articles for article (PubMed ID: 30822244)
1. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
[TBL] [Abstract][Full Text] [Related]
2. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with functional activity and oxidative modification of alpha-1-antitrypsin in COPD patients.
Milovanovic V; Topic A; Milinkovic N; Lazic Z; Ivosevic A; Radojkovic D; Rankov AD
Pulmonology; 2024; 30(2):122-129. PubMed ID: 34674978
[TBL] [Abstract][Full Text] [Related]
3. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
[TBL] [Abstract][Full Text] [Related]
4. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
5. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
6. Secretory leukocyte proteinase inhibitor, alpha-1-antitrypsin deficiency and emphysema: Preliminary study, speculation and an hypothesis.
Ayad MS; Knight KR; Burdon JG; Brenton S
Respirology; 2003 Jun; 8(2):175-80. PubMed ID: 12753532
[TBL] [Abstract][Full Text] [Related]
7. [Changes of serum elastase, alpha 1-antitrypsin, procollagen III peptide and malonaldehyde in smokers with and without chronic obstructive pulmonary diseases].
Chen X; Cheng X; Li J; Zhang H; Hua Y; Xu X; Zhao Q; Li Q; Qin F; Yu L; Li Z; Li Y
Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):178-80. PubMed ID: 11798647
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
Turino GM; Ma S; Cantor JO; Lin YY
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S336-40. PubMed ID: 27564670
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
10. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
[TBL] [Abstract][Full Text] [Related]
11. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
Kueppers F
Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
[TBL] [Abstract][Full Text] [Related]
12. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
13. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases.
Topic A; Stankovic M; Divac-Rankov A; Petrovic-Stanojevic N; Mitic-Milikic M; Nagorni-Obradovic L; Radojkovic D
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1282-6. PubMed ID: 22971141
[TBL] [Abstract][Full Text] [Related]
15. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
[TBL] [Abstract][Full Text] [Related]
16. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
[TBL] [Abstract][Full Text] [Related]
17. Airflow limitation in Japanese smokers: significance of serum neutrophil elastase/alpha(1)-proteinase inhibitor ratio and FEV(1) (%pred) adjusted by pack-years.
Hoshino Y; Nagai S; Koyama H; Okuda K; Nishimura K; Miki H; Hamada K; Izumi T
Respiration; 2000; 67(4):372-7. PubMed ID: 10940789
[TBL] [Abstract][Full Text] [Related]
18. Trace elements and oxidative stress in chronic obstructive pulmonary disease.
Isik B; Isik RS; Ceylan A; Calik O
Saudi Med J; 2005 Dec; 26(12):1882-5. PubMed ID: 16380766
[TBL] [Abstract][Full Text] [Related]
19. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Carleo A; Chorostowska-Wynimko J; Koeck T; Mischak H; Czajkowska-Malinowska M; Rozy A; Welte T; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():829-837. PubMed ID: 28331304
[TBL] [Abstract][Full Text] [Related]
20. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
